News

Boston Scientific, Emblem, S-ICD, UNTOUCHED study, TV-ICDs, MADIT-RIT study

Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the Emblem subcutaneous implantable defibrillator (S-ICD). The device is...

defibrillators, older heart patients, Duke Medicine study, Tracy Wang

Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the...

CIEDs, UCSF, UC San Francisco, defibrillator, pacemaker, monitoring, SCD

The current monitoring of patients with cardiac implantable electronic devices (CIEDs) may be underestimating device problems, according to UC San Francisco researchers. They propose systematic...

PRAETORIAN trial, first U.S. patients, ICD, subcutaneous, S-ICD, defibrillators

The Valley Hospital has been selected as the United States Coordinating Center for the international PRAETORIAN trial analyzing implantable cardioverter-defibrillators (ICDs). The trial will...

Clinical trial results showed that full-body magnetic resonance imaging (MRI) scans do not affect the Medtronic Evera MRI SureScan implantable cardioverter defibrillator’s (ICD) ability to detect...

Greatbatch Medical, Myopore Sutureless Myocardial Pacing Lead

A new epicardial pacing lead has been cleared by the U.S. Food and Drug Adminitysration (FDA) as an option for the implant of a pacemaker, defibrillator, or cardiac resynchronization therapy (CRT...

HRS, remote monitoring, RM, standard of care, CIEDs

A new expert consensus statement by the Heart Rhythm Society (HRS) recommends remote monitoring (RM) become standard of care for patients with cardiovascular implantable electronic devices (CIEDs...

Geneva Healthcare, Geneva Healthcare Suite 2.0, HRS, patient engagement

Geneva Healthcare will showcase a set of new features on The Geneva Healthcare Suite – a technology platform for managing data from cardiac devices – at Heart Rhythm Society's annual scientific...

St. Jude Medical, ICD, MRI-conditional, CE mark, Europe, pacemakers

St. Jude Medical Inc. announced CE Mark approval of expanded labeling for its Ellipse implantable cardioverter defibrillator (ICD), in addition to its Durata and Optisure defibrillation leads. The...

Accreditation for Cardiovascular Excellence, standards, EP, ICDs, guidelines

Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and implantable cardioverter defibrillator (ICD) standards for accreditation. Driven by...

May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place...

Boston Scientific, investors, cardiology, growth, expansion

Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth strategies at a meeting with the investment community May 1.

ScottCare, Ambucor, HRS, 2015, ECG, remote monitoring

The ScottCare Corp. announced it will highlight Ambucor, the company’s employable labor service division for CIED monitoring, at the 2015 Heart Rhythm Society Scientific Sessions in Boston, May 13...

Biotronik, DX, ICD, Inventra, Itrevia, FDA, ultra-high energy

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (ICDs) that can deliver ultra-high energy on the first...

Boston Scientific, S-ICD, long-term data, TV-ICD, trial

The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific Corp. S-ICD System (subcutaneous implantable...

Emblem S-ICD, implantable cardioverter defibrillator, Boston Scientific, FDA, CE

Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) and CE Mark approval of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) system. The Emblem S-ICD system is a...

Biotronik, ProMRI, AFFIRM, trial, ICD, MRI systems, EP Lab

Biotronik announced that its ProMRI and ProMRI AFFIRM studies have been published in Heart Rhythm, the official journal of the Heart Rhythm Society, validating the...

Quadripolar lead, Medtronic, Attain, VivaQuad, CRT-D

There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient monitoring to avoid needless shocks, the...

EP lab, Implantable Cardioverter Defibrillators, Heart Failure

Boston Scientific Corporation announced the launch and first U.S. implant of its line of Extended Longevity (EL) implantable cardioverter defibrillators (ICD), including Dynagen EL and Inogen EL...

Cardiac Resynchonization Therapy (CRT), Implantable cardioverster defibrillators

Medtronic announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm.